RT Journal Article
SR Electronic
T1 Critical care demand and intensive care supply for patients in Japan with COVID-19 at the time of the state of emergency declaration in April 2020: a descriptive analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.20.20136150
DO 10.1101/2020.06.20.20136150
A1 Fujii, Yosuke
A1 Hirota, Kiichi
YR 2020
UL http://medrxiv.org/content/early/2020/10/03/2020.06.20.20136150.abstract
AB Background The coronavirus disease 2019 (COVID-19) pandemic overwhelms Japan’s intensive care capacity. This study aimed to determine the number of patients with COVID-19 who required intensive care and to compare the numbers with Japan’s intensive care capacity.Methods Publically available datasets were used to obtain the number of confirmed patients with COVID-19 undergoing mechanical ventilation and extracorporeal membrane oxygenation (ECMO) between February 15 and July 19, 2020, to determine and compare intensive care unit (ICU) and attending bed needs for patients with COVID-19, and to estimate peak ICU demands in Japan.Results During the epidemic peak in late April, 11443 patients (1.03/10000 adults) had been infected, 373 patients (0.034/10000 adults) were in ICU, 312 patients (0.028/10000 adults) were receiving mechanical ventilation, and 62 patients (0.0056/10000 adults) were under ECMO per day. At the peak of the epidemic, the number of infected patients was 651% of designated beds, and the number of patients requiring intensive care was 6.0% of ICU beds, 19.1% of board-certified intensivists, and 106% of designated medical institutions in Japan.Conclusions The number of critically ill patients with COVID-19 continued to rise during the pandemic, exceeding the number of designated beds but not exceeding ICU capacity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the branding program as a world-leading research university on intractable immune and allergic diseases from MEXT Japan to K.H.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and analyzed during the current study are available from the corresponding author on reasonable request.WHOWorld Health OrganizationECMOExtracorporeal membranous oxygenationCOVID-19Coronavirus induced disease 2019SARS-CoV-2Severe acute respiratory syndrome coronavirus 2ICUIntensive care unitJSICMThe Japanese Society of Intensive Care MedicineCRISISCRoss Icu Searchable Information SystemIQRInterquartile range